HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suzanne L Topalian Selected Research

Disease Progression

1/2021Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
4/2014Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suzanne L Topalian Research Topics

Disease

68Neoplasms (Cancer)
05/2021 - 01/2002
49Melanoma (Melanoma, Malignant)
11/2021 - 01/2002
12Renal Cell Carcinoma (Grawitz Tumor)
11/2019 - 01/2002
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019 - 07/2010
7Merkel Cell Carcinoma
01/2021 - 07/2013
4Body Weight (Weight, Body)
05/2018 - 07/2003
4Kidney Neoplasms (Kidney Cancer)
01/2016 - 07/2003
4Prostatic Neoplasms (Prostate Cancer)
10/2014 - 03/2002
4Colorectal Neoplasms (Colorectal Cancer)
10/2014 - 07/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 07/2017
3Neoplasm Metastasis (Metastasis)
06/2017 - 07/2009
2Disease Progression
01/2021 - 04/2014
2Carcinoma (Carcinomatosis)
11/2019 - 03/2002
2Fowlpox
04/2006 - 08/2003
2Thrombocytopenia (Thrombopenia)
04/2005 - 01/2002
2Lymphopenia (Lymphocytopenia)
04/2005 - 05/2002
1Squamous Cell Carcinoma of Head and Neck
01/2021
1Infections
01/2021
1Vulvar Neoplasms (Vulvar Cancer)
11/2019
1Skin Neoplasms (Skin Cancer)
11/2018
1Hodgkin Disease (Hodgkin's Disease)
07/2017
1Virus Diseases (Viral Diseases)
07/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2010
1Adenocarcinoma
10/2010

Drug/Important Bio-Agent (IBA)

16AntigensIBA
11/2018 - 03/2002
12Immune Checkpoint InhibitorsIBA
01/2021 - 04/2012
12NivolumabIBA
01/2021 - 01/2013
10Peptides (Polypeptides)IBA
01/2017 - 07/2003
9EpitopesIBA
11/2013 - 10/2002
6Biomarkers (Surrogate Marker)IBA
05/2021 - 11/2005
6Proteins (Proteins, Gene)FDA Link
05/2018 - 03/2002
6Interleukin-2 (IL2)IBA
04/2006 - 05/2002
5B7-H1 AntigenIBA
01/2020 - 09/2015
5AntibodiesIBA
11/2018 - 12/2005
5CTLA-4 AntigenIBA
01/2016 - 07/2003
5VaccinesIBA
07/2015 - 08/2003
5LigandsIBA
04/2015 - 06/2012
5Neoplasm Antigens (Tumor Antigens)IBA
03/2012 - 05/2002
4InterferonsIBA
01/2021 - 03/2012
4pembrolizumabIBA
01/2021 - 06/2016
4IpilimumabIBA
10/2020 - 05/2006
4DNA (Deoxyribonucleic Acid)IBA
07/2013 - 04/2003
4Monophenol Monooxygenase (Tyrosinase)IBA
04/2006 - 08/2002
3CytokinesIBA
11/2019 - 03/2012
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2018 - 10/2006
3Immunoglobulins (Immunoglobulin)IBA
07/2015 - 06/2015
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2015 - 05/2002
3HLA-DR1 Antigen (HLA DR1 Antigen)IBA
09/2012 - 04/2007
3InterleukinsIBA
12/2005 - 08/2003
3HLA-A*02:01 antigenIBA
11/2005 - 08/2003
2Transcription Factors (Transcription Factor)IBA
11/2019 - 07/2017
2Interleukin-10 (Interleukin 10)IBA
11/2019 - 09/2015
2Monoclonal AntibodiesIBA
10/2019 - 09/2005
2EnzymesIBA
07/2017 - 10/2002
2Programmed Cell Death 1 ReceptorIBA
07/2017 - 01/2016
2Formaldehyde (Formol)FDA Link
01/2016 - 09/2015
2ParaffinIBA
01/2016 - 09/2015
2Interferon-gamma (Interferon, gamma)IBA
09/2015 - 07/2015
2Messenger RNA (mRNA)IBA
03/2013 - 04/2003
2Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA
09/2012 - 04/2007
2Histocompatibility Antigens Class IIIBA
09/2012 - 06/2010
2PhosphopeptidesIBA
06/2010 - 07/2009
2fludarabineIBA
04/2005 - 05/2002
2AutoantigensIBA
04/2004 - 07/2003
2Differentiation AntigensIBA
05/2003 - 10/2002
2Polynucleotide Adenylyltransferase (Polymerase, Poly A)IBA
04/2003 - 10/2002
1Phosphotransferases (Kinase)IBA
01/2021
1CarcinogensIBA
01/2021
1SolutionsIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2020
1Interleukin-27 (Interleukin 27)IBA
11/2019
1Mono-SIBA
11/2019
1Small Interfering RNA (siRNA)IBA
11/2019
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
07/2017
1Interleukin-23 (Interleukin 23)IBA
07/2017
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
07/2017
1DisulfidesIBA
01/2017
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2017
1GlycopeptidesIBA
01/2017
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
07/2015
1Blocking AntibodiesIBA
02/2015
1Immunomodulating AgentsIBA
10/2014
1Circulating Tumor DNAIBA
01/2014
1Indicators and Reagents (Reagents)IBA
01/2014
1HLA-DR4 Antigen (HLA DR4 Antigen)IBA
11/2013
1Azacitidine (5 Azacytidine)FDA Link
11/2013
1Ataxia Telangiectasia Mutated ProteinsIBA
06/2012
1Drug CombinationsIBA
08/2011
1Dihydrotachysterol (AT 10)IBA
07/2010
1Mitochondrial DNA (mtDNA)IBA
06/2008

Therapy/Procedure

34Therapeutics
11/2021 - 08/2002
26Immunotherapy
01/2021 - 03/2002
7Drug Therapy (Chemotherapy)
01/2021 - 05/2002
3Aftercare (After-Treatment)
01/2020 - 04/2014
2Neoadjuvant Therapy
01/2021 - 01/2021
2Castration
10/2014 - 06/2012
2Intravenous Infusions
07/2010 - 01/2002
2Intravenous Administration
09/2003 - 01/2002
1Salvage Therapy
01/2021
1Investigational Therapies (Experimental Therapy)
11/2013